Dermatology
RSSArticles
-
Management of the Hospitalized Diabetic Patient
-
Clinical Briefs in Primary Care Supplement
-
Treating Onychomycosis: A Head-to-Head Comparison of Terbinafine and Itraconazole
-
Pharmacology Update: Alosetron Hydrochloride Tablets (Lotronex — GlaxoSmithKline) Reintroduction
-
Is Viagra Safe?
-
cagA+ H pylori Strains are Disappearing
-
Acute Lung Injury and ARDS
-
Venous Thromboembolism: How Long to Treat?
Patients who receive extended anticoagulation are protected from recurrent VTE while receiving long-term therapy. The clinical benefit is maintained after anticoagulation is discontinued, but the magnitude of the benefit is less pronounced. -
Pharmacology Update: Deferasirox Tablets for Oral Suspension (Exjade®)
Following a priority review, the FDA has approved deferasirox, the first oral iron chelator for the treatment of chronic iron overload due to transfusions. It will be marketed by Novartis Pharmaceuticals as Exjade®. -
Clinical Briefs in Primary Care supplement